School Systems Struggle With Lunchroom Costs
FRIDAY, May 13 (HealthDay News) -- Every day, Carol Chong
oversees the serving of about 300,000 meals to hungry students in
the fourth-largest school district in the United States.
Fat Cats, Dogs Developing Diabetes, Report Finds
FRIDAY, May 13 (HealthDay News) -- Like all good pet owners,
Christine Wong didn't hesitate to go to a veterinary clinic near
her home in Austin, Texas, when her cat, Kiki, wasn't feeling
well.
Teens Follow Mom's Lead on Tanning Beds
FRIDAY, May 13 (HealthDay News) -- Many white teen girls and
young women in the United States who use indoor tanning beds have
mothers who also use tanning beds, a survey finds.
Family Medical History Murky for Many
FRIDAY, May 13 (HealthDay News) -- Doctors rely on a patient's
knowledge of his or her family medical history in assessing cancer
risk, but these recollections are not always dependable.
Teaching Kids to Make Healthier Choices May Pay Off
FRIDAY, May 13 (HealthDay News) -- A program to boost heart
health in students at a middle school in Michigan was so successful
that it's being expanded to about 20 middle schools in the state,
researchers say.
Older Caregivers at Greater Risk for Cognitive Decline
FRIDAY, May 13 (HealthDay News) -- Caring for a loved one who is
ill is always stressful, but older people caring for a spouse who
has dementia may face an increased risk for cognitive problem or
dementia themselves, researchers report.
Eat Less, Live Longer?
FRIDAY, May 13 (HealthDay News) -- People who cut their daily
caloric intake by 25 percent or more may live longer than those who
do not, a new study suggests.
Brain Surgery for Mary Tyler Moore to Remove Benign Tumor
THURSDAY, May 12 (HealthDay News) -- Representatives for veteran
TV sitcom star Mary Tyler Moore report that she entered a facility
for surgery to remove a meningioma -- a type of tumor, usually
benign, that can occur on the meninges, the brain's protective
outer membrane.
FDA Approves New Drug to Fight Hepatitis C
FRIDAY, May 13 (HealthDay News) -- The U.S. Food and Drug
Administration late Friday gave approval to Victrelis (boceprevir),
one of a new class of drugs aimed at fighting chronic hepatitis C
infection.